These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 10037009

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Cd20 Expression and Effects on Outcome of Relapsed/ Refractory Diffuse Large B Cell Lymphoma after Treatment with Rituximab.
    Rasheed AA, Samad A, Raheem A, Hirani SI, Shabbir- Moosajee M.
    Asian Pac J Cancer Prev; 2018 Feb 26; 19(2):331-335. PubMed ID: 29479962
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Safety and efficacy of high-dose cyclophosphamide, etoposide and ranimustine regimen followed by autologous peripheral blood stem cell transplant for patients with diffuse large B-cell lymphoma.
    Kobayashi Y, Hatta Y, Sugitani M, Hojo A, Nakagawa M, Kusuda M, Uchino Y, Takahashi H, Kiso S, Hirabayashi Y, Yagi M, Kodaira H, Kurita D, Miura K, Iriyama N, Kobayashi S, Kura Y, Horikoshi A, Sawada U, Takeuchi J, Takei M.
    Leuk Lymphoma; 2014 Nov 26; 55(11):2514-9. PubMed ID: 24491027
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Treatment response and overall outcome of patients with relapsed and refractory peripheral T-cell lymphoma compared to diffuse large B-cell lymphoma.
    Puig N, Wang L, Seshadri T, al-Farsi K, Keating A, Crump M, Kuruvilla J.
    Leuk Lymphoma; 2013 Mar 26; 54(3):507-13. PubMed ID: 22897731
    [Abstract] [Full Text] [Related]

  • 48. Autologous stem cell transplantation for T and null cell CD30-positive anaplastic large cell lymphoma: analysis of 64 adult and paediatric cases reported to the European Group for Blood and Marrow Transplantation (EBMT).
    Fanin R, Ruiz de Elvira MC, Sperotto A, Baccarani M, Goldstone A.
    Bone Marrow Transplant; 1999 Mar 26; 23(5):437-42. PubMed ID: 10100556
    [Abstract] [Full Text] [Related]

  • 49. Randomized Trial Comparing R-CHOP Versus High-Dose Sequential Chemotherapy in High-Risk Patients With Diffuse Large B-Cell Lymphomas.
    Cortelazzo S, Tarella C, Gianni AM, Ladetto M, Barbui AM, Rossi A, Gritti G, Corradini P, Di Nicola M, Patti C, Mulé A, Zanni M, Zoli V, Billio A, Piccin A, Negri G, Castellino C, Di Raimondo F, Ferreri AJ, Benedetti F, La Nasa G, Gini G, Trentin L, Frezzato M, Flenghi L, Falorio S, Chilosi M, Bruna R, Tabanelli V, Pileri S, Masciulli A, Delaini F, Boschini C, Rambaldi A.
    J Clin Oncol; 2016 Nov 20; 34(33):4015-4022. PubMed ID: 28199143
    [Abstract] [Full Text] [Related]

  • 50. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma.
    Philip T, Guglielmi C, Hagenbeek A, Somers R, Van der Lelie H, Bron D, Sonneveld P, Gisselbrecht C, Cahn JY, Harousseau JL.
    N Engl J Med; 1995 Dec 07; 333(23):1540-5. PubMed ID: 7477169
    [Abstract] [Full Text] [Related]

  • 51. Treatment of relapsing refractory diffuse large cell lymphoma after matched unrelated donor bone marrow transplant with immunosuppression withdrawal and rituximab.
    Wong R, de Lima M, Couriel D, Giralt S, Hosing C, Shahjahan M, Cheng YC, Bruton J, Champlin R, Khouri I.
    Leuk Lymphoma; 2003 May 07; 44(5):829-32. PubMed ID: 12802922
    [Abstract] [Full Text] [Related]

  • 52. Impact of high-dose salvage therapy (BEAM) on overall survival in younger patients with advanced large-cell lymphomas entered into BNLI trials.
    Linch DC, Vaughan Hudson B, Anderson L, Vaughan Hudson G.
    Ann Oncol; 1997 May 07; 8 Suppl 1():63-5. PubMed ID: 9187433
    [Abstract] [Full Text] [Related]

  • 53. Upfront autologous stem cell transplantation for untreated high-risk diffuse large B-cell lymphoma in patients up to 60 years of age.
    Takasaki H, Hashimoto C, Fujita A, Matsumoto K, Taguchi J, Kuwabara H, Yamazaki E, Koharazawa H, Fujita H, Fujisawa S, Ishii Y, Yamamoto W, Motomura S, Tomita N, Ishigatsubo Y, Sakai R.
    Clin Lymphoma Myeloma Leuk; 2013 Aug 07; 13(4):404-9. PubMed ID: 23763919
    [Abstract] [Full Text] [Related]

  • 54. Efficacy of upfront high-dose chemotherapy plus rituximab followed by autologous peripheral blood stem cell transplantation for untreated high-intermediate-, and high-risk diffuse large B-cell lymphoma: a multicenter prospective phase II study (JSCT-NHL04).
    Murayama T, Fukuda T, Okumura H, Sunami K, Sawazaki A, Maeda Y, Tsurumi H, Uike N, Hidaka T, Takatsuka Y, Eto T, Tsuda H, Fujisaki T, Miyamoto T, Tsuneyoshi N, Iyama S, Nagafuji K, Harada M.
    Int J Hematol; 2016 Jun 07; 103(6):676-85. PubMed ID: 27084252
    [Abstract] [Full Text] [Related]

  • 55. Survival and freedom from progression in autotransplant lymphoma patients is independent of stem cell source: further follow-up from the original randomised study to assess engraftment.
    Kottaridis PD, Peggs K, Schmitz N, Dreger P, Boogaerts MA, Ferrant A, Demuynck HM, Zander A, Link H, Matcham J, Linch DC, Borkett K, Goldstone AH.
    Leuk Lymphoma; 2002 Mar 07; 43(3):531-6. PubMed ID: 12002756
    [Abstract] [Full Text] [Related]

  • 56. Autologous stem cell transplantation in elderly patients (> or =60 years) with diffuse large B-cell lymphoma: an analysis based on data in the European Blood and Marrow Transplantation registry.
    Jantunen E, Canals C, Rambaldi A, Ossenkoppele G, Allione B, Blaise D, Conde E, Tilly H, Cook G, Clark F, Gallamini A, Haynes A, Mounier N, Dreger P, Pfreundschuh M, Sureda A, EBMT Lymphoma Working Party.
    Haematologica; 2008 Dec 07; 93(12):1837-42. PubMed ID: 18838474
    [Abstract] [Full Text] [Related]

  • 57. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.
    De Rosa L, Lalle M, Pandolfi A, Ruscio C, Amodeo R.
    Ann Hematol; 2002 Oct 07; 81(10):575-81. PubMed ID: 12424539
    [Abstract] [Full Text] [Related]

  • 58. Is there any role for transplantation in the rituximab era for diffuse large B-cell lymphoma?
    Gisselbrecht C.
    Hematology Am Soc Hematol Educ Program; 2012 Oct 07; 2012():410-6. PubMed ID: 23233612
    [Abstract] [Full Text] [Related]

  • 59. [High-dose chemotherapy with autologous bone marrow transplantation: 11 years' experience in Zurich].
    Jost LM, Honegger HP, Stahel RA.
    Schweiz Med Wochenschr; 2000 Jan 22; 130(3):60-9. PubMed ID: 10683881
    [Abstract] [Full Text] [Related]

  • 60. Induction chemotherapy followed by up-front autologous stem cell transplantation may have a survival benefit in high-risk diffuse large B-cell lymphoma patients.
    Shin HJ, Yoon DH, Lee HS, Oh SY, Yang DH, Kang HJ, Chong SY, Park Y, Do Y, Lim SN, Jo JC, Lee WS, Chung JS, Consortium for Improving Survival of Lymphoma.
    Exp Hematol; 2016 Jan 22; 44(1):3-13. PubMed ID: 26325332
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.